Disease Info Card

Beta Thalassemia

Information about Beta Thalassemia: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Beta Thalassemia

Most recent studies have shown that Beta Thalassemia shares some biological mechanisms with alpha-thalassemia, anemia, anemia-hemolytic, anemia-sickle-cell, cooleys-anemia, heart-failure, hematological-disease, hemoglobinopathies, hemolysis-(disorder), hepatitis, hereditary-diseases, hypochromic-anemia, iron-deficiency, iron-deficiency-anemia, iron-overload, sickle-cell-trait, thalassemia, thalassemia-intermedia, thalassemia-minor, thalassemia-trait.

Among the many pathways, these few ones have gauged particular interests from scientists studying Beta Thalassemia, and have been seen in publications frequently: Bone Resorption, Cell Death, Cell Growth, Cell Proliferation, Coagulation, Dna Amplification, Excretion, Insulin Secretion, Methylation, Ovulation, Pathogenesis, Phagocytosis, Platelet Activation, Platelet Aggregation, Proteolysis, Rna Processing, Rna Splicing, Secretion, Translation, Transport

Quite a number of genes have been found to play important roles in Beta Thalassemia, such as ATP6V0A2, BEST1, DMD, EPO, G6PD, GPHA2, HBA1, HBB, HBG2, IGF1, INS, KIDINS220, PMCH, SGCA, TF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.